1. Home
  2. TXMD vs NOTE Comparison

TXMD vs NOTE Comparison

Compare TXMD & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.79

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.77

Market Cap

39.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
NOTE
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
39.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TXMD
NOTE
Price
$1.79
$1.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$29.25
AVG Volume (30 Days)
125.2K
224.5K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$2,796,000.00
$102,673,000.00
Revenue This Year
$427.09
N/A
Revenue Next Year
N/A
$0.55
P/E Ratio
$291.37
N/A
Revenue Growth
75.19
N/A
52 Week Low
$0.70
$1.75
52 Week High
$2.44
$24.36

Technical Indicators

Market Signals
Indicator
TXMD
NOTE
Relative Strength Index (RSI) 55.84 24.39
Support Level $1.46 $1.88
Resistance Level $2.01 $2.15
Average True Range (ATR) 0.18 0.18
MACD 0.00 0.03
Stochastic Oscillator 55.17 0.00

Price Performance

Historical Comparison
TXMD
NOTE

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

Share on Social Networks: